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Abstract
Background: Asian-specific single nucleotide polymorphism (SNPs) (rs3782886) is reported to be associated with
myocardial infarction; sarcopenia is reported to be associated with coronary subclinical atherosclerosis. On the other
hand, short stature has been revealed as an independent risk factor for cardiovascular disease. However, no studies
have reported on the association between sarcopenia and short stature nor on the impact of rs3782886 on this
association.
Methods: Since reduced maximum voluntary tongue pressure against the palate (MTP) reflects one aspect of
sarcopenia, we conducted a cross-sectional study of 537 community-dwelling elderly Japanese participants aged
60–89 years who had participated in a general health checkup in 2015. Short stature was defined as values at or
under the 25th percentile, and reduced MTP was defined as the lowest tertile of the study population (<158.0 cm
and <26.5 kPa for men, <145.0 cm and <24.1 kPa for women).
Results: Independent of classical cardiovascular risk factors, short stature was revealed to be positively associated
with reduced MTP. The adjusted-odds ratio (OR) and 95% confidence interval (CI) of reduced MTP for short stature
was 1.87 (1.19, 2.94). We also found that independent of known cardiovascular risk factors, with the non-minor
homo of rs3782886 taken as the reference group, the adjusted OR and 95% CI for short stature and reduced MTP of
the minor homo allele were 3.06 (1.23, 7.63) and 3.26 (1.33, 8.03), respectively.
Conclusion: Short stature is independently associated with reduced MTP, with Asian-specific SNPs possibly playing
an important role in this association.
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Background
Asian-specific single nucleotide polymorphism (SNP)
rs3782886 in breast cancer suppressor protein-associated
protein (BRAP) is reported to be associated with a risk of
myocardial infarction [1]. Another study reported that
BRAP activates inflammatory cascades and increases the
risk of carotid atherosclerosis [2]. Since Japanese individ-
uals are known to have a short stature, and short stature
may constitute an inflammatory disadvantage [3] and a
risk of carotid atherosclerosis [4], SNP rs3782886 may
therefore be associated with short stature.
On the other hand, sarcopenia is also reported to be
associated with coronary subclinical atherosclerosis in
the very elderly [5], and age-associated changes to the
immune system that induce part of the inflammatory re-
action have been suggested to contribute to sarcopenia
[6]. Furthermore, reduced maximum voluntary tongue
pressure against the palate (MTP) is reported to be asso-
ciated with sarcopenia [7, 8].
Short stature may therefore be associated with de-
creased MTP by indicating possible inflammatory disad-
vantage in participants with short stature [3].
Additionally, SNP rs3782886 might also be associated
with reduced tongue pressure as an indicator of Asian-
specific inflammatory disadvantage leading to sarcopenia
in elderly Japanese participants.
On the other hand, height is regarded as a marker of
childhood social and physical conditions [4, 9, 10]. Since
BMI, which is reported to be associated with increased
risk of disease [11], is largely influenced by current cir-
cumstances, studies limited to participants with lower
BMI might allow elucidation of the influence of child-
hood circumstances (including genetic factors) by weak-
ening the influence of current circumstances [9, 12].
To clarify these associations, we conducted a cross-
sectional study of 537 community-dwelling elderly
Japanese aged 60–89 years who had participated in gen-
eral health checkup in 2015.
Methods
Study population
The total number of residents of Goto city aged 60–89
in 2015 (estimated by the National Institute of Popula-
tion and Social Security Research in March 2013) was
16,176 [13]. Among them, 579 participants were taking
an annual medical checkup, of which 33 did not agree to
participate in our present study (participation rate
94.3%). Therefore, the study population comprised 546
Japanese elderly residents from the western rural com-
munities of the Goto Islands, who undertook an annual
medical checkup in 2015 as recommended by the
Japanese government.
Those without MTP data (n = 9) were excluded, leav-
ing 537 participants with a mean age of 73.4 years
(standard deviation (SD) 7.5; range 60–89) enrolled in
the study.
Data collection and laboratory measurements
Trained interviewers obtained information on clinical
characteristics. Body weight and height were mea-
sured with an automatic body composition analyzer
(BF-220; Tanita, Tokyo, Japan), and body mass index
(BMI; kg/m2) was calculated. Systolic and diastolic
blood pressure were recorded at rest. Primarily fasting
blood samples were collected in a siliconized tube.
Triglycerides (TG) and creatinine were measured enzy-
matically. HDL-cholesterol (HDL) was measured using a
direct method, while hemoglobin A1c (HbA1c) was mea-
sured using the latex coagulation method at SRL, Inc.
(Tokyo, Japan). Genomic DNA was extracted from 2 mL
of whole peripheral blood with GENE PREP STAR NA-
480 (KURABO). Subject DNA was typed for SNP
rs3782886 (BRAP on chromosome 12q24.12) using the
HybProbe method with LightCycler 480 (Roshe). MTP
was evaluated by the method proposed by Tsuga et
al. using the JMS tongue pressure measurement de-
vice, Orarize (TPM-01, JMS Co., Ltd. Hiroshima,
Japan) [14, 15]. This tongue pressure measuring device
consists of a disposable oral probe. To measure MTP, par-
ticipants were placed in a relaxed sitting position and
asked to compress the disposal balloon by raising their
tongue using maximum voluntary effort.
Since a previous study of community-dwelling elderly
individuals reported that individuals in the lowest tertiles
of tongue pressure had lower scores in the muscle func-
tion test (handgrip strength, jump height, and jump
power) [8] than individuals in other tertiles, we defined
reduced MTP as a tongue pressure in the lowest tertile
of the study population (<26.5 kPa for men and
<24.1 kPa for women). And short stature was defined as
a height level at or under the 25th percentile of the
study population (<158.0 cm for men and <145.0 cm for
women) since these participants may have cardiovascu-
lar risk factors determined by childhood social and phys-
ical conditions (including genetic factors) [9, 12].
Statistical analysis
Clinical characteristics of the SNP rs3782886 genotype
were compared. Differences in mean ± SD values or
prevalence of potential confounding factors by SNP
rs3782886 genotypes were calculated. A trend test was
performed with a regression model for mean values, and
a logistic regression model was used for proportion.
Logistic regression models were used to calculate odds
ratios (ORs) and 95% confidence intervals (CIs) to deter-
mine the influence of height and short stature on reduced
MTP among sex-combined model and sex-specific
models. We also used logistic regression models to
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calculate ORs and 95% CIs to determine the influence of
SNP rs3782886 on short stature and reduced MTP in a
sex-combined model and among women. And a further
analysis of the total participants limited to those with a
BMI < 25 kg/m2 was also conducted since this might elu-
cidate the influence of childhood circumstances (including
genetic factors).
Adjustments for confounding factors were made into
two models. In the first model (model 1), we adjusted
only for sex and age. In the second (model 2), we in-
cluded other possible confounding factors, such as BMI
(kg/m2), systolic blood pressure (mmHg), alcohol con-
sumption [never drinker, former drinker, current drinker
(<23 g/week, 23 to 45g/week, 46 to 68 g/week, ≥69 g/
week)], smoking status (never smoker, former smoker,
current smoker), history of stroke (yes, no), HDL-
cholesterol (mg/dL), triglycerides (mg/dL), HbA1C (%),
and serum creatinine (mg/dL).
All statistical analyses were performed with the SAS
system for Windows (version 9.4; SAS Inc., Cary, NC).
All p values for statistical tests were two-tailed, with
values of <0.05 regarded as being statistically significant.
Results
Of the total study population, regarding the rs3782886
genotype, 326 participants were major homo (A/A), 187
hetero (A/G), and 24 minor homo (G/G).
Characteristics of the present study population are
shown in Table 1. Current drinker status and height
were found to be significantly associated with genotype.
Table 2 shows the ORs and 95% CIs for reduced MTP
in relation to height level. Independent of known
cardiovascular risk factors, height was inversely associ-
ated with faster reduced MTP. The classical cardiovas-
cular risk factor-adjusted OR and 95% CI of reduced
MTP for a decrement of 1 SD (standard deviation) in
height (6.55 cm for men and 5.63 cm for women) was
1.27 (1.02–1.58). We also evaluated the impact of short
stature on reduced MTP and found a positive associ-
ation between the two. With non-short stature as the
reference group, the adjusted OR and 95% CI of reduced
MTP for short stature was 1.87 (1.19, 2.94). When we
conducted a sex-specific analysis, we found these associ-
ations to be essentially true both for men and women.
With the highest tertiles of height taken as reference,
the fully adjusted ORs and 95% CIs of reduced MTP
were 1.70 (0.81, 3.55) for men and 1.95 (1.07, 3.54) for
women.
Table 3 shows the OR and 95% CI for short stature in
relation to the rs3782886 genotype. Independent of
known cardiovascular risk factors, among the total par-
ticipants, a positive association was found between
rs3782886 minor homo and short stature. Compared
with non-minor homo (A/A and A/G), the fully adjusted
OR and 95% CI of short stature for minor homo (G/G)
was 3.06 (1.23, 7.63) for the total participants and 1.73
(0.57, 5.24) for women only.
Table 4 shows the OR and 95% CI for reduced
MTP in relation to the rs3782886 genotype. Inde-
pendent of known cardiovascular risk factors, a posi-
tive association was found between rs3782886 minor
homo and reduced MTP. Compared with non-minor
homo (A/A and A/G), the fully adjusted OR and 95%
CI of reduced MTP for minor homo (G/G) was 3.26
Table 1 Characteristics of the study population by rs3782886 genotype
rs3782886 p value
Major homo (A/A) Hetero type (A/G) Minor homo (G/G)
No. of participants 326 187 24
Men, % 35.9 43.9 25.0 0.081
Age, years 73.1 ± 7.5 73.3 ± 7.7 74.2 ± 7.6 0.609
Current drinker, % 28.5 13.4 0.0 <0.001
Current smoker, % 6.1 5.9 4.2 0.925
History of stroke 4.6 4.3 12.5 0.200
Body mass index (BMI), kg/m2 23.3 ± 3.2 24.1 ± 3.7 23.6 ± 3.2 0.039
Systolic blood pressure, mmHg 140 ± 18 139 ± 17 137 ± 17 0.841
Diastolic blood pressure, mmHg 80 ± 11 78 ± 12 80 ± 12 0.134
Serum HDL-cholesterol (HDL), mg/dL 59 ± 15 56 ± 14 57 ± 13 0.146
Serum triglycerides (TG), mg/dL 104 ± 61 102 ± 54 99 ± 47 0.861
Hemoglobin A1c (HbA1c), % 5.7 ± 0.5 5.7 ± 0.5 5.8 ± 0.7 0.845
Serum creatinine, mg/dL 0.75 ± 0.21 0.79 ± 0.21 0.77 ± 0.22 0.140
Height, cm 154.3 ± 8.8 154.2 ± 8.8 148.7 ± 7.6 0.011
Values: mean ± standard deviation
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(1.33, 8.03) for total participants and 3.04 (1.04, 8.85)
for women only.
Table 5 shows the OR and 95% CI for short stature
and reduced MTP in relation to the rs3782886 genotype
among participants with a BMI < 25 kg/m2. Compared
with the analysis for all participants (including both
BMI < 25 kg/m2 and BMI ≥ 25 kg/m2), the associations
of short stature and reduced MTP in relation to
rs3782886 were slightly stronger. Compared with non-
minor homo (A/A and A/G), the fully adjusted ORs and
95% CIs of short stature and reduced MTP for minor
homo (G/G) were 4.21 (1.36, 12.98) and 4.31 (1.41,
13.11), respectively.
Discussion
Our present study revealed height to be inversely associ-
ated with reduced MTP among community-dwelling
elderly Japanese participants. Additionally, a significant
association was seen between Asian-specific SNPs and
short stature and reduced MTP. These results indicate
that SNPs play an important role, at least in part, on the
association between height and reduced MTP among
elderly Japanese participants.
Our additional analysis which was limited to partici-
pants with a BMI < 25 kg/m2 showed slightly stronger
associations with regard to short stature and reduced
MTP in relation to SNP rs3782886. Since an analysis
limited to participants with a lower BMI might elucidate
the influence of childhood circumstances (including gen-
etic factors) [9, 12], the additional analysis also supports
the present conclusion that a genetic factor may influ-
ence the association between height and reduced MTP.
The possible mechanism underlying the positive asso-
ciation between short stature and reduced MTP and the
role of SNP rs3782886 in this association involves low-
grade inflammation. SNP rs3782886 is known to be lo-
cated on the BRAP gene on chromosome 12q24, and
higher expression of BRAP with the minor allele (G al-
lele) is associated with increased risk of atherosclerosis
through enhancing the degree of inflammation via
Table 2 Odds ratios (OR) and 95% confidence intervals (CI) for reduced maximum voluntary tongue pressure against the palate
(MTP) in relation to height
Height p for trend 1 SD decrement in height
(6.55 cm for men and
5.63 cm for women)
Q1 (short) Q2 Q3 Q4 (tall)
Total participants
No. at risk 132 135 134 136
No. of cases (percentage) 65 (49.2) 48 (35.6) 36 (26.9) 31 (22.8)
Model 1 1.93 (1.08, 3.43) 1.35 (0.77, 2.37) 1.01 (0.57, 1.79) 1.00 0.012 1.24 (1.00, 1.54)
1.69 (1.10, 2.61) 1.00 0.017
Model 2 2.19 (1.20, 3.98) 1.35 (0.76, 2.39) 1.11 (0.61, 1.99) 1.00 0.007 1.27 (1.02, 1.58)
1.87 (1.19, 2.94) 1.00 0.007
Men
No. at risk 50 52 52 51
No. of cases (percentage) 23 (46.0) 22 (42.3) 14 (26.9) 19 (19.6)
Model 1 1.97 (0.76, 5.15) 1.75 (0.68, 4.53) 1.09 (0.41, 2.86) 1.00 0.096 1.19 (0.84, 1.69)
1.51 (0.75, 3.03) 1.00 0.035
Model 2 2.14 (0.79, 5.81) 1.55 (0.58, 4.17) 1.17 (0.42, 3.21) 1.00 0.102 1.19 (0.82, 1.72)
1.70 (0.81, 3.55) 1.00 0.162
Women
No. at risk 82 83 82 85
No. of cases (percentage) 42 (51.2) 26 (31.3) 22 (26.8) 21 (24.7)
Model 1 2.00 (0.97, 4.12) 1.14 (0.57, 2.28) 0.97 (0.48, 1.97) 1.00 0.054 1.28 (0.98, 1.68)
1.92 (1.09, 3.36) 1.00 <0.001
Model 2 2.16 (1.00, 4.66) 1.21 (0.59, 2.48) 1.08 (0.51, 2.26) 1.00 0.052 1.31 (0.98, 1.73)
1.95 (1.07, 3.54) 1.00 0.029
Model 1: adjusted only for sex and age. Model 2: further adjusted for body mass index, systolic blood pressure, alcohol consumption (never drinker, former
drinker, current drinker [<23, 23–45, 46–68, and ≥69 g/week]), smoking status (never smoker, former smoker, current smoker), history of stroke, HDL-cholesterol,
triglycerides, HbA1C, and serum creatinine. Reduced maximum voluntary tongue pressure against the palate is defined as the lowest tertile of the study population
(<26.5 kPa for men and <24.1 kPa for women). Height values for men are <158.0 cm for Q1, 158.0–161.8 cm for Q2, 161.9–166.5 cm for Q3, and >166.5 cm for Q4 and
for women are <145.0 cm for Q1, 145.0–148.9 cm for Q2, 149.0–152.7 cm for Q3, and >152.7 cm for Q4
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Table 3 Odds ratios (OR) and 95% confidence intervals (CI) for short stature in relation to rs3782886 genotype
rs3782886 p for trend Minor allele frequencies
Non-minor homo Minor homo
Major homo (A/A) Hetero (A/G) (G/G)
Total participants
No. at risk 326 187 24
No. of cases (percentage) 72 (22.1) 49 (26.2) 11 (45.8)
Model 1 1.00 1.21 (0.78, 1.89) 3.05 (1.22, 7.61) 0.040 1.44 (1.02, 2.05)
1.00 2.85 (1.16, 6.99) 0.023
Model 2 1.00 1.23 (0.77, 1.98) 3.35 (1.31, 8.59) 0.033 1.50 (1.03, 2.18)
1.00 3.06 (1.23, 7.63) 0.017
Women
No. at risk 209 105 18
No. of cases (percentage) 48 (23.0) 27 (25.7) 7 (38.7)
Model 1 1.00 1.19 (0.66, 2.16) 1.94 (0.63, 5.94) 0.257 1.29 (0.83, 2.02)
1.00 1.83 (0.61, 5.49) 0.284
Model 2 1.00 1.22 (0.66, 2.27) 1.87 (0.60, 5.79) 0.261 1.30 (0.82, 2.06)
1.00 1.73 (0.57, 5.24) 0.330
Model 1: adjusted only for age (and sex for total participants). Model 2: further adjusted for body mass index, systolic blood pressure, alcohol consumption (never
drinker, former drinker, current drinker [<23, 23–45, 46–68, and ≥69 g/week]), smoking status (never smoker, former smoker, current smoker), history of stroke,
HDL-cholesterol, triglycerides, HbA1C, and serum creatinine. Short stature is defined as a height level at or under the 25th percentile of the study population
(<158.0 cm for men and <145.0 cm for women)
Table 4 Odds ratios (OR) and 95% confidence intervals (CI) for reduced maximum voluntary tongue pressure against the palate
(MTP) in relation to rs3782886 genotype
rs3782886 p for trend Minor allele frequencies
Non-minor homo Minor homo
Major homo (A/A) Hetero (A/G) (G/G)
Total participants
No. at risk 326 187 24
No. of cases (percentage) 112 (34.4) 54 (28.9) 14 (58.3)
Model 1 1.00 0.72 (0.48, 1.09) 2.66 (1.10, 6.42) 0.805 1.04 (0.76, 1.43)
1.00 2.97 (1.25, 7.09) 0.014
Model 2 1.00 0.76 (0.49, 1.17) 2.92 (1.17, 7.29) 0.566 1.11 (0.79, 1.55)
1.00 3.26 (1.33, 8.03) 0.010
Women
No. at risk 209 105 18
No. of cases (percentage) 65 (31.1) 35 (33.3) 11 (61.1)
Model 1 1.00 1.12 (0.67, 1.87) 3.37 (1.21, 9.42) 0.067 1.44 (0.98, 2.12)
1.00 3.25 (1.18, 8.93) 0.022
Model 2 1.00 1.14 (0.66, 1.95) 3.18 (1.07, 9.43) 0.088 1.43 (0.95, 2.15)
1.00 3.04 (1.04, 8.85) 0.042
Model 1: adjusted only for sex and age. Model 2: further adjusted for body mass index, systolic blood pressure, alcohol consumption (never drinker, former
drinker, current drinker [<23, 23–45, 46–68, and ≥69 g/week]), smoking status (never smoker, former smoker, current smoker), history of stroke, HDL-cholesterol,
triglycerides, HbA1C, and serum creatinine. Reduced maximum voluntary tongue pressure against the palate is defined as the lowest tertile of the study population
(<26.5 kPa for men and <24.1 kPa for women)
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activation of NF-κB protein [2, 16]. In addition, we re-
ported in a previous study that short stature constitutes
an inflammatory disadvantage among middle-aged Japa-
nese men [3] and that height is inversely associated with
carotid atherosclerosis in overweight men [4]. In our
present study, we found that SNP rs3782886 with the
minor homo (G/G) allele is positively associated with
short stature. Therefore, short stature may result in an in-
flammatory disadvantage that relates to SNP rs3782886
with the minor homo (G/G) genotype.
On the other hand, decreased tongue pressure is asso-
ciated with sarcopenia [7, 8], and sarcopenia is associ-
ated with coronary subclinical atherosclerosis in the very
elderly [5]. Since atherosclerosis, which is one of the
major risk factors for coronary artery disease, is known
as an inflammatory condition [17], such a condition may
form a complicated network, resulting in the present
study’s observations. A previous study that reported the
unfavorable effects of systematic inflammation on
muscle strength in the elderly also supports this mech-
anism [18]. Further investigations are necessary to clarify
the network involved.
Another possible mechanism at play is lower skeletal
muscle capillarization resulting in the positive association
between short stature and reduced MTP. Previously, we
reported height to be an indicator of vascular main-
tenance capacity in older men [19]; sarcopenia is also
reported to be associated with lower skeletal muscle
capillarization [20]. Lower skeletal muscle capillariza-
tion caused by lower vascular maintenance capacity,
which is associated with short stature, might result in
reduced MTP.
A summary of the possible mechanism underlying the
results of our present study is shown in Fig. 1. Age-
related low-grade inflammation and low vascular
maintenance capacity should take important roles in
progression of sarcopenia.
Our present study is the first to report the impact of
height on tongue pressure, as well as the first to reveal a
significant association between SNP rs3782886 and short
stature and reduced MTP. Since SNP rs3782886 is an
inflammation-related genetic factor [1, 2], our present
results represent an efficient tool to clarify the genetic
influence of age-related inflammation on reduced MTP.
Potential limitations of this study warrant consideration.
Although SNP rs3782886 is significantly associated with
short stature and reduced MTP, no data was available with
regard to the evaluation of endothelial function. Further
analyses that include endothelial function-related data
such as flow-mediated dilation (FMD) will be
Table 5 Odds ratios (OR) and 95% confidence intervals (CI) for short stature and reduced maximum voluntary tongue pressure
against the palate (MTP) in relation to the rs3782886 genotype among participants with BMI < 25 kg/m2
rs3782886 p for trend Minor allele frequencies
Non-minor homo Minor homo
Major homo (A/A) Hetero (A/G) (G/G)
Short stature
Total participants (BMI < 25 kg/m2)
No. at risk 232 123 17
No. of cases (percentage) 56 (24.1) 30 (24.4) 9 (52.9)
Model 1 1.00 0.96 (0.55, 1.68) 4.18 (1.37, 12.75) 0.127 1.39 (0.91, 2.13)
1.00 4.23 (1.41, 12.72) 0.010
Model 2 1.00 1.03 (0.57, 1.86) 4.25 (1.35, 13.39) 0.092 1.47 (0.94, 2.31)
1.00 4.21 (1.36, 12.98) 0.012
Reduced maximum voluntary tongue pressure against the palate (MTP)
Total participants (BMI < 25 kg/m2)
No. at risk 232 123 17
No. of cases (percentage) 82 (35.3) 44 (35.8) 11 (64.7)
Model 1 1.00 1.00 (0.62, 1.61) 3.56 (1.21, 10.53) 0.149 1.32 (0.91, 1.92)
1.00 3.57 (1.22, 10.43) 0.020
Model 2 1.00 1.11 (0.66, 1.86) 4.49 (1.45, 13.92) 0.054 1.49 (0.99, 2.24)
1.00 4.31 (1.41, 13.11) 0.010
Model 1: adjusted only for sex and age. Model 2: further adjusted for body mass index, systolic blood pressure, alcohol consumption (never drinker, former
drinker, current drinker [<23, 23–45, 46–68, and ≥69 g/week]), smoking status (never smoker, former smoker, current smoker), history of stroke, HDL-cholesterol,
triglycerides, HbA1C, and serum creatinine. Short stature is defined as a height level at or under the 25th percentile of the study population (<158.0cm for men
and <145.0 cm for women). Reduced maximum voluntary tongue pressure against the palate is defined as the lowest tertile of the study population (<26.5 kPa
for men and <24.1 kPa for women)
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necessary. Since only four cases of short stature and
three cases of reduced MTP among men with the
minor homo allele (n = 6) were available, a male-
specific analysis was not able to be carried out. Fur-
ther investigation with a larger study population will
be necessary. And since our present study population
targeted elderly participants, height data may be con-
founded by age-related physical changes such as ky-
phosis and compression fracture of the spine,
although we found no significant differences between
age and SNP genotypes in the present study popula-
tion. Finally, even though a positive association be-
tween short stature and reduced MTP was revealed,
causal relationships were not able to be established
since this was a cross-sectional study.
Conclusion
In conclusion, height is inversely associated with reduced
MTP among community-dwelling elderly Japanese partici-
pants. Additionally, Asian-specific SNPs were also found
to be significantly associated with short stature and re-
duced MTP. These results indicate that genetic factors
may play an important role, at least in part, on the associ-
ation between height and reduced MTP among elderly
Japanese participants.
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Fig. 1 The possible mechanism underlying the positive association between short stature and reduced MTP and the role of SNP rs3782886. In
our present study, a short stature was positively associated with reduced MTP, b rs3782886 minor homo was positively associated with short
stature, and c rs3782886 minor homo was positively associated reduced MTP
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